Agios Pharmaceuticals (AGIO) Free Cash Flow Growth (5y) (2017 - 2026)
Agios Pharmaceuticals (AGIO) Free Cash Flow Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | Agios Pharmaceuticals | 2.21 Bn | 1.47 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.58% |
| Dec 31, 2025 | -62.01% |
| Sep 30, 2025 | 5.48% |
| Jun 30, 2025 | -21.87% |
| Mar 31, 2025 | -0.26% |
| Dec 31, 2024 | -7.61% |
| Sep 30, 2024 | 0.79% |
| Jun 30, 2024 | 4.07% |
| Mar 31, 2024 | 1.06% |
| Dec 31, 2023 | 0.36% |
| Sep 30, 2023 | 0.42% |
| Jun 30, 2023 | 0.29% |
| Mar 31, 2023 | 0.99% |
| Dec 31, 2022 | 3.12% |
| Sep 30, 2022 | 0.91% |
| Jun 30, 2022 | -3.52% |
| Mar 31, 2022 | -6.22% |
| Dec 31, 2021 | -7.88% |
| Sep 30, 2021 | -27.95% |
| Jun 30, 2021 | -19.46% |